## BACKGROUND. Variant CD44 splice products, especially CD44 variant 6 (CD44v6),
Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival
β Scribed by Roderick M. Quiros; Geetha Rao; Janet Plate; Jules E. Harris; Gregory J. Brunn; Jeffrey L. Platt; Paolo Gattuso; Richard A. Prinz; Xiulong Xu
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 395 KB
- Volume
- 106
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract YKLβ40 is a glycoprotein secreted by macrophages, neutrophils and malignant tumor cells. Elevated serum levels of YKLβ40 are associated with poor prognosis in several malignancies. In this study, we examined the prognostic value of serum YKLβ40 before treatment and during followβup in p
## Abstract For patients with brain tumors identification of diagnostic and prognostic markers in easy accessible biological material, such as plasma or cerebrospinal fluid (CSF), would greatly facilitate patient management. MICβ1/GDF15 (growth differentiation factor 15) is a secreted protein of th
W e read with interest the results from the study of serum albu- min and liver metastasis in patients with carcinomas of unknown primary site by Seve et al. 1 We can present some results from our unpublished study in patients with cancer of unknown primary site in which we explored a set of possible